Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | PRKCA | P17252 | 3/20 | 0.44 |
| ▸ | EP300 | Q09472 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 3/20 | 0.43 |
| ▸ | TERT | O14746 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | FABP4 | P15090 | 2/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | PPARD | Q03181 | 2/20 | 0.43 |
| ▸ | PPARA | Q07869 | 2/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7027317 | 0.80 | ASAH2 (0.48) | LMNAPRKCAFAAHTERTCYP1A2 | |
| SCHEMBL7022930 | 0.80 | ASAH2 (0.48) | LMNAPRKCAFAAHTERTCYP1A2 | |
| SCHEMBL7022923 | 0.80 | ASAH2 (0.48) | LMNAPRKCAFAAHTERTCYP1A2 | |
| SCHEMBL9997844 | 0.77 | EP300 (0.44) | LMNAPRKCAEP300FAAHTERT | |
| SCHEMBL9997651 | 0.77 | EP300 (0.44) | LMNAPRKCAEP300FAAHTERT | |
| SCHEMBL9997653 | 0.77 | EP300 (0.44) | LMNAPRKCAEP300FAAHTERT | |
| SCHEMBL9997846 | 0.77 | EP300 (0.44) | LMNAPRKCAEP300FAAHTERT | |
| SCHEMBL8844592 | 0.77 | F7 (0.51) | LMNAPRKCAFAAHTERTCYP1A2 | |
| SCHEMBL27984797 | 0.76 | EP300 (0.45) | LMNAEP300FAAHTERTCYP1A2 | |
| SCHEMBL233313 | 0.76 | EP300 (0.45) | LMNAEP300FAAHTERTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3917928-A1 | THEOPHYLLINE DERIVATIVES WITH NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND RELATIVE USE | ISAGRO S.p.A. (IT) | 2021-12-08 | — | — | EP | disclosed |
| WO-2020157668-A1 | THEOPHYLLINE DERIVATIVES WITH NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND RELATIVE USE | ISAGRO S.P.A. (IT) | 2020-08-06 | — | — | WO | disclosed |
| US-20080293676-A1 | Insecticidal Agents Based on Selected Insecticides and Safeners | BAYER CROPSCIENCE AG (DE) | 2008-11-27 | — | — | US | disclosed |
| US-20080167374-A1 | PESTICIDE COMPOSITION AND METHOD OF USE | LOVELAND PRODUCTS, INC. (US) | 2008-07-10 | — | — | US | disclosed |
| US-6818670-B2 | THE NOVEL ACTIVE COMPOUND COMBINATIONS OF CERTAIN CYCLIC KETOENOLS AND THE ACTIVE COMPOUNDS (1) TO (95) LISTED IN THE DESCRIPTION HAVE VERY GOOD INSECTICIDAL AND ACARICIDAL PROPERTIES. | BAYER AKTIENGESELLSCHAFT (DE) | 2004-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293676-A1 | Insecticidal Agents Based on Selected Insecticides and Safeners | ACHE, NCS1, HCN1 | LMNA 3078/4885PRKCA 1899/4885EP300 1660/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.